CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Daniel Lubman

OPENALEX: A5056532577↗ORCID: 0000-0002-6747-1937↗

Affiliations

Organizations

Australian Regenerative Medicine Instituteauthorship · AU Deakin Universityauthorship · AU Eastern Healthauthorship · AU Hologic (Germany)authorship · DE Melbourne Healthauthorship · AU Monash Healthauthorship · AU Monash Medical Centreauthorship · AU Monash Universityauthorship · AU Orygenauthorship · AU Orygen Youth Healthauthorship · AU The University of Melbourneauthorship · AU University of Wollongongauthorship · AU

Public evidence

4 connected articles

Development of Goal Management Training+ (GMT+) for methamphetamine use disorder through collaborative design: A process description2021 · medRxiv White matter alterations associated with chronic cannabis use disorder: a structural network and fixel-based analysis.2024 · Europe PMC A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol.2024 · Europe PMC Hippocampal harms, protection and recovery following regular cannabis use.2016 · Europe PMC

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 09/09/2026.

Daniel Lubman - Medical Cannabis Research Engine